SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech completes NAFDAC inspection at Valthera facility in Gujarat

08 Oct 2025 Evaluate

Concord Biotech has completed NAFDAC inspection (National Agency for Food and Drug Administration) at its Oral Solid Dosage (OSD) Unit-2, facility located at Valthera, Gujarat. The inspection was conducted from October 06, 2025 to October 07, 2025.

This achievement underscores its unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of its operations. 

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1070.70 -10.55 (-0.98%)
20-Apr-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.00
Dr. Reddys Lab 1237.40
Cipla 1237.70
Zydus Lifesciences 941.15
Lupin 2333.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×